MID-VOLUME · HOSP-MID

cannabidiol Side Effects

cannabidiol (also sold as Epidiolex) sits MID-VOLUME #225 of 524 by FAERS report count. Lead signal: HOSP-MID - 29.3% mention hospitalization (6,502 reports). Demographics and serious-outcome tables follow.

Data updated 2026-05-15

22,227
FAERS reports

FDA Adverse Event Reporting System extract for cannabidiol. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-MID. How figures are compiled.

cannabidiol: 29.3% mention hospitalization (6,502 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #225 of 524 by FAERS report count.

Mid-book FAERS page for cannabidiol (Epidiolex) (22,227 reports). Signature HOSP-MID. Dominant age band on file: 0-17. Educational reference only.

Counts from the openFDA FAERS extract (2010–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.

SEIZURE leads 5,791 of 22,227 reports

SEIZURE
5,791
HOSPITALISATION
2,073
DIARRHOEA
1,695
SOMNOLENCE
1,242
DEATH
1,204
FATIGUE
1,169
WEIGHT DECREASED
824
WEIGHT INCREASED
800
VOMITING
707
DECREASED APPETITE
685
NAUSEA
643
CONDITION AGGRAVATED
601
PNEUMONIA
593
PRODUCT ADMINISTRATION INTERRUPTED
524
DRUG INTERACTION
513
INSOMNIA
489

Who reports · age peak 0-17 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 5,434 (49%)
Male 5,601 (51%)
Unknown 9

Age peak 0-17 (2,603 reports)

0-17 2,603 (44%)
18-44 1,869 (32%)
45-64 847 (14%)
65-74 361 (6%)
75+ 210 (4%)

FAERS filings rising toward 2025

10
14
15
16
17
18
19
20
21
22
23
24
25

Reactions in Death Reports

Death-mentioned subset is HEAVY here (1,726 reports, 7.8%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 1,196
SEIZURE 82
PNEUMONIA 62
CARDIAC ARREST 56
RESPIRATORY FAILURE 50
HOSPITALISATION 44
SUDDEN UNEXPLAINED DEATH IN EPILEPSY 40
DRUG ABUSE 33
COMPLETED SUICIDE 27
FATIGUE 26
SEPSIS 25
ANAEMIA 21
COVID-19 21
TOXICITY TO VARIOUS AGENTS 21
PYREXIA 20
THROMBOCYTOPENIA 20
FOETAL DEATH 19
LEUKOCYTOSIS 19

Reactions in Hospitalization Reports

Hospitalization mid-share (6,502, 29.3%). Co-reported reactions:

Reaction Reports
HOSPITALISATION 2,063
SEIZURE 1,941
PNEUMONIA 471
DIARRHOEA 266
VOMITING 256
SOMNOLENCE 246
FATIGUE 223
PRODUCT ADMINISTRATION INTERRUPTED 220
WEIGHT DECREASED 220
EMERGENCY CARE 216
FALL 195
PYREXIA 178
COVID-19 167
URINARY TRACT INFECTION 159
NAUSEA 151
DECREASED APPETITE 144
How to read cannabidiol FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)

FAERS holds 22,227 voluntary reports linked to cannabidiol (Epidiolex), 2010-2025. Death is listed on 1,726 (7.8%). Hospitalization appears on 6,502 (29.3%). Top co-reported indication: Product Used For Unknown Indication.

Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 29.3% mention hospitalization (6,502 reports).

Read with cannabidiol

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.